04 Aug, 2021 RNAi Roundtable: Givosiran, for the Treatment of Acute Hepatic Porphyria
Posted at 13:31h
in Capella
On August 4, 2021, we hosted an online RNAi Roundtable to review the progress with givosiran, for the treatment of acute hepatic porphyria.
Access the replay
View the presentation
Akin Akinc, Ph.D.
Vice President & General Manager, Givosiran
Marianne Sweetser, M.D., Ph.D.
Senior Distinguished Fellow, Clinical Development
Laurent Placidi, Ph.D., PharmD.
Senior Director, Global Marketing, Givosiran
